Concepedia

Shintaro Hiro

SH

Statistics

Publications

8

Citations

164

H-Index

8

Active since

1982

Affiliations

Pfizer (Japan)(Current)

Tanaka Holdings (Japan)

Shintaro Hiro is an author at Pfizer (Japan) specializing in medicine, pharmacology, and pharmacotherapy.

Publications per year

1982–2025

8

Publications

8

Randomized, Double-Blind Trial to Evaluate the Safety of Apixaban With Antiplatelet Therapy After Acute Coronary Syndrome in Japanese Patients (APPRAISE-J)

Hisao Ogawa, Shinya Goto, Masunori Matsuzaki et al. · Circulation Journal · 2013 · 38 citations · Full text

, , +17

Efficacy, Safety and Tolerability of Fesoterodine in Asian Patients with Overactive Bladder

Osamu Yamaguchi, Osamu Nishizawa, Masayuki Takeda et al. · LUTS Lower Urinary Tract Symptoms · 2011 · 32 citations

, , +17

Efficacy of Fesoterodine on Nocturia and Quality of Sleep in Asian Patients With Overactive Bladder

Osamu Yokoyama, Shintaro Hiro, Shinichi Hotta et al. · Urology · 2014 · 21 citations

, , +11

Long-term safety and efficacy of daily recombinant human growth hormone treatment in Japanese short children born small for gestational age: final report from an open and multi-center study

Toshiaki Tanaka, Susumu Yokoya, Yuko Hoshino et al. · Clinical Pediatric Endocrinology · 2018 · 20 citations · Full text

, , +17

Acute endocarditis in drug addicts: surgical treatment for gram-negative sepsis.

Sidney Levitsky, Robert B. Mammana, Norman A. Silverman et al. · PubMed · 1982 · 16 citations

, , +17

1–5 of 8